Pneumonia

Feature Article

Efficacy of Antibiotics for Community-Acquired Pneumonia Evaluated

Efficacy of Antibiotics for Community-Acquired Pneumonia Evaluated

Study finds that over one-fifth of those prescribed an antibiotic for community-acquired pneumonia experience treatment failure.

Latest News

Higher Risk for Pneumonia in HIV Does Not Mean Worse Outcomes

Higher Risk for Pneumonia in HIV Does Not Mean Worse Outcomes

A Barcelona study found that patients with HIV required no special treatment for pneumonia compared with healthy individuals.

Pneumonia Risk Higher in Asthma Patients Using Inhaled Corticosteroid

Pneumonia Risk Higher in Asthma Patients Using Inhaled Corticosteroid

Use of inhaled corticosteroids is linked to increased risk of pneumonia in patents with asthma.

Can Neutrophil-to-Lymphocyte Ratio Predict Mortality in CAP?

Can Neutrophil-to-Lymphocyte Ratio Predict Mortality in CAP?

Neutrophil-to-lymphocyte ratio (NLR) can predict 30-day mortality for elderly adults with community-acquired pneumonia (CAP).

AATS: Guidelines for Empyema Management Released

AATS: Guidelines for Empyema Management Released

The American Association for Thoracic Surgery has release guidelines on the treatment of empyema from complications of pneumonia.

Higher Risk of Community-Acquired Pneumonia With Certain T2D Drugs

Higher Risk of Community-Acquired Pneumonia With Certain T2D Drugs

Patients with type 2 diabetes may be at greater risk of developing community-acquired pneumonia when using thiazolidinediones with metformin compared to treatment with a sulfonylurea and metformin.

Benzodiazepine Use Increases Pneumonia Risk in Alzheimer Disease

Benzodiazepine Use Increases Pneumonia Risk in Alzheimer Disease

Risk for pneumonia should be considered when weighing the benefits and risks of benzodiazepines in patients with Alzheimer disease.

Pneumonia Rate in Children Decreased With PCV10 Vaccine

Pneumonia Rate in Children Decreased With PCV10 Vaccine

The rate of pneumonia decreased with the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) in vaccine-eligible children and older, unvaccinated children.

Treatment of CAP: Phase 3 Results of Novel Tetracycline

Treatment of CAP: Phase 3 Results of Novel Tetracycline

Paratek announced positive outcomes for their phase 3 trial of omadacycline for treating community-acquired bacterial pneumonia.

Pneumonia Risk in Dementia Increases With Proton Pump Inhibitor Use

Pneumonia Risk in Dementia Increases With Proton Pump Inhibitor Use

Age, male gender, underlying cerebrovascular disease, chronic pulmonary disease, congestive heart failure, diabetes mellitus, and usage of antipsychotics were independent risk factors of pneumonia among dementia patients with PPI usage.

High Cardiac Troponin Levels Predict Mortality in CAP

High Cardiac Troponin Levels Predict Mortality in CAP

Elevated cardiac troponin levels were highly predictive of both in-hospital and long-term mortality in patients admitted for community-acquired pneumonia (CAP).

Sign Up for Free e-newsletters